Cancer Institute Clinical Trials - General
#110304 - Killeen
#110127 - Round Rock
Merck V212-011: "A Phase III Randomized, Placebo-Controlled, Clinical Trial to Study the Safety and Efficacy of V212 in Adult Patients with Solid Tumor or Hematologic Malignancy"
Study Location: Temple Main Campus, Killeen Cancer Center, Round Rock
For more information or to enroll in a study please call: 1-254-724-5407